sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has filed Form 8.3 regarding its position in Mural Oncology plc. As of September 22, 2025, Vanguard disclosed its interest in 664,792 $0.01 ordinary shares, representing 3.85% of Mural Oncology's relevant securities.
The filing, made under Rule 8.3 of the Irish Takeover Panel Act, 1997, includes information about purchases and sales of securities. Vanguard purchased 32 shares at $2.07 each and sold 55,500 and 7,049 shares at prices of $2.07 and $2.08, respectively.
No cash-settled or stock-settled derivatives, agreements, or other dealings have been disclosed. Additionally, there are no indemnities, agreements, or understandings related to options or voting rights specified in the form.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.